UFT: Mechanism of drug action

Citation
Ch. Kohne et Gj. Peters, UFT: Mechanism of drug action, ONCOLOGY-NY, 14(10), 2000, pp. 13-18
Citations number
55
Categorie Soggetti
Oncology
Journal title
ONCOLOGY-NEW YORK
ISSN journal
08909091 → ACNP
Volume
14
Issue
10
Year of publication
2000
Supplement
9
Pages
13 - 18
Database
ISI
SICI code
0890-9091(200010)14:10<13:UMODA>2.0.ZU;2-4
Abstract
The mechanism of action of fluorouracil (5-FU) and the oral fluoropyrimidin es and the importance of biochemical modulation and inhibition of dihydropy rimidine dehydrogenase for oral application of the prodrugs of 5-FU are dis cussed. The regulation of thymidylate synthase, as well as its roles as a t arget for antineoplastic activity and in drug resistance, are also mentione d. The more downstream events of 5-FU action and their implication in 5-FU resistance, whit the possible involvement of the Fas/FasL system and the pr oteins associated with apoptosis regulation, are highlighted. Also discusse d is the suggestion that the oral 5-FU prodrug tegafur and uracil (UFT) and its metabolites function as an angiogenesis inhibitor.